Stevanato Group (NYSE:STVN) Issues FY24 Earnings Guidance

by · The Cerbat Gem

Stevanato Group (NYSE:STVN – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided EPS guidance of €0.47-0.49 for the period, compared to the consensus EPS estimate of $0.48. The company issued revenue guidance of €1.09-1.11 billion, compared to the consensus revenue estimate of $1.09 billion. Stevanato Group also updated its FY 2024 guidance to 0.517-0.539 EPS.

Stevanato Group Stock Performance

Shares of STVN traded up €3.12 ($3.43) during mid-day trading on Tuesday, hitting €22.50 ($24.73). The stock had a trading volume of 1,509,331 shares, compared to its average volume of 508,341. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.13 and a current ratio of 1.74. Stevanato Group has a 52 week low of €16.56 ($18.20) and a 52 week high of €34.73 ($38.16). The business has a fifty day moving average price of €19.57 and a 200-day moving average price of €20.33.

Stevanato Group (NYSE:STVN – Get Free Report) last issued its earnings results on Tuesday, August 6th. The company reported €0.09 ($0.10) earnings per share for the quarter, missing the consensus estimate of €0.10 ($0.11) by (€0.01) (($0.01)). Stevanato Group had a net margin of 11.27% and a return on equity of 10.89%. The company had revenue of €259.60 million for the quarter, compared to analysts’ expectations of €254.92 million. During the same quarter in the prior year, the company earned $0.15 earnings per share. The company’s revenue was up 1.7% compared to the same quarter last year. As a group, analysts anticipate that Stevanato Group will post 0.5 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have commented on STVN shares. Citigroup decreased their price target on Stevanato Group from $30.00 to $28.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th. Morgan Stanley dropped their price objective on Stevanato Group from $26.00 to $22.00 and set an “equal weight” rating on the stock in a research note on Monday, July 15th.

Get Our Latest Analysis on Stevanato Group

Stevanato Group Company Profile

(Get Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

See Also